484 related articles for article (PubMed ID: 23207444)
1. Circulating tumor cells in lung cancer.
Young R; Pailler E; Billiot F; Drusch F; Barthelemy A; Oulhen M; Besse B; Soria JC; Farace F; Vielh P
Acta Cytol; 2012; 56(6):655-60. PubMed ID: 23207444
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.
O'Flaherty JD; Gray S; Richard D; Fennell D; O'Leary JJ; Blackhall FH; O'Byrne KJ
Lung Cancer; 2012 Apr; 76(1):19-25. PubMed ID: 22209049
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells as promising novel biomarkers in solid cancers.
Lianidou ES; Strati A; Markou A
Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of circulating tumor cells in breast cancer patients.
Tao M; Ma D; Li Y; Zhou C; Li Y; Zhang Y; Duan W; Xu X; Wang R; Wu L; Liu H
Breast Cancer Res Treat; 2011 Aug; 129(1):247-54. PubMed ID: 21512769
[TBL] [Abstract][Full Text] [Related]
5. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
7. [Circulating tumor cells: liquid biopsy].
Alix-Panabières C; Pierga JY
Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
[TBL] [Abstract][Full Text] [Related]
8. Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics.
Onstenk W; Gratama JW; Foekens JA; Sleijfer S
Cancer Treat Rev; 2013 Nov; 39(7):691-700. PubMed ID: 23683721
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells.
Hayes DF; Smerage JB
Prog Mol Biol Transl Sci; 2010; 95():95-112. PubMed ID: 21075330
[TBL] [Abstract][Full Text] [Related]
10. Looking back, to the future of circulating tumor cells.
Friedlander TW; Premasekharan G; Paris PL
Pharmacol Ther; 2014 Jun; 142(3):271-80. PubMed ID: 24362084
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cells: evolving evidence and future challenges.
Dotan E; Cohen SJ; Alpaugh KR; Meropol NJ
Oncologist; 2009 Nov; 14(11):1070-82. PubMed ID: 19897536
[TBL] [Abstract][Full Text] [Related]
12. Global gene expression profiling of circulating tumor cells.
Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score.
Kolostova K; Broul M; Schraml J; Cegan M; Matkowski R; Fiutowski M; Bobek V
Anticancer Res; 2014 Jul; 34(7):3641-6. PubMed ID: 24982381
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal characterization: alternative to simple CTC detection in two clinical trials.
Barriere G; Riouallon A; Renaudie J; Tartary M; Rigaud M
Anticancer Res; 2012 Aug; 32(8):3363-9. PubMed ID: 22843916
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells.
Książkiewicz M; Markiewicz A; Zaczek AJ
Pathobiology; 2012; 79(4):195-208. PubMed ID: 22488297
[TBL] [Abstract][Full Text] [Related]
16. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.
Danova M; Torchio M; Mazzini G
Expert Rev Mol Diagn; 2011 Jun; 11(5):473-85. PubMed ID: 21707456
[TBL] [Abstract][Full Text] [Related]
17. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
Sieuwerts AM; Mostert B; Bolt-de Vries J; Peeters D; de Jongh FE; Stouthard JM; Dirix LY; van Dam PA; Van Galen A; de Weerd V; Kraan J; van der Spoel P; Ramírez-Moreno R; van Deurzen CH; Smid M; Yu JX; Jiang J; Wang Y; Gratama JW; Sleijfer S; Foekens JA; Martens JW
Clin Cancer Res; 2011 Jun; 17(11):3600-18. PubMed ID: 21505063
[TBL] [Abstract][Full Text] [Related]
18. Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients.
Giordano A; Giuliano M; De Laurentiis M; Eleuteri A; Iorio F; Tagliaferri R; Hortobagyi GN; Pusztai L; De Placido S; Hess K; Cristofanilli M; Reuben JM
Breast Cancer Res Treat; 2011 Sep; 129(2):451-8. PubMed ID: 21710134
[TBL] [Abstract][Full Text] [Related]
19. Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients.
Tokudome N; Ito Y; Takahashi S; Kobayashi K; Taira S; Tsutsumi C; Oto M; Oba M; Inoue K; Kuwayama A; Masumura K; Nakayama Y; Watanabe C; Hatake K
Breast Cancer; 2011 Jul; 18(3):195-202. PubMed ID: 21465230
[TBL] [Abstract][Full Text] [Related]
20. Controversies in circulating tumor cell count during therapy.
Raimondi C; Gradilone A; Gazzaniga P
Expert Rev Mol Diagn; 2013 Jun; 13(5):499-507. PubMed ID: 23782256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
